February 27, 2018 / 6:26 AM / 8 months ago

BRIEF-Basilea Pharmaceutica FY Operating Loss At CHF 14.1 million

Feb 27 (Reuters) - BASILEA PHARMACEUTICA AG:

* FY ‍54% INCREASE IN TOTAL REVENUE, AMOUNTING TO CHF 101.5 MILLION​

* FY OPERATING LOSS REDUCED BY 68% TO CHF 14.1 MILLION

* ‍CASH POSITION AS OF YEAR-END 2017 INCREASED TO CHF 310.7 MILLION​

* ‍NET LOSS IN 2017 WAS REDUCED TO CHF 19.4 MILLION (2016: CHF 51.3 MILLION)​

* OUTLOOK 2018: ANTICIPATES TOTAL REVENUE OF APPROXIMATELY CHF 105-115 MILLION

* OPERATING LOSS IN 2018 IS ESTIMATED AT APPROXIMATELY CHF 10-20 MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below